+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Medicinal Neutral Borosilicate Glass Market - Global Forecast 2026-2032- Product Image
Medicinal Neutral Borosilicate Glass Market - Global Forecast 2026-2032- Product Image
Sale

Medicinal Neutral Borosilicate Glass Market - Global Forecast 2026-2032

  • Report

  • 184 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6283261
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Medicinal Neutral Borosilicate Glass: Executive Overview

Medicinal neutral borosilicate glass is used for pharmaceutical containers and laboratory applications where chemical durability, thermal resistance, dimensional stability, and low extractables are important. The market is shaped by injectable-drug packaging requirements, biologics handling, sterile manufacturing, regulatory compliance, and the need to protect product quality throughout storage and administration. Competitive relevance depends on validated raw materials, controlled forming processes, inspection capability, and dependable supply continuity.

Packaging Integrity and Supply Resilience Are Reshaping the Landscape

The landscape is shifting toward higher-performance primary packaging, tighter control of particulate and extractables, and greater compatibility with sensitive formulations. Growth in biologics, vaccines, complex injectables, and prefilled delivery systems is increasing attention to container closure integrity, dimensional consistency, delamination resistance, and compatibility with sterilization processes. At the same time, pharmaceutical manufacturers are strengthening dual-sourcing, regional qualification, traceability, and continuity planning in response to logistics disruptions and stricter quality expectations.

Artificial Intelligence Strengthens Quality, Maintenance, and Traceability

Artificial intelligence can improve medicinal glass operations by detecting visual defects, dimensional deviations, contamination risks, and forming anomalies through automated image analysis. Predictive models can support furnace and forming-equipment maintenance, optimize process parameters, and identify relationships between production conditions and container performance. In pharmaceutical supply chains, AI can also assist with batch-record review, deviation triage, demand sensing, and serialization analytics. Adoption still requires validated systems, representative training data, cybersecurity controls, human oversight, and documented compliance with applicable quality requirements.

Regional Insights: Regulation, Manufacturing Depth, and Healthcare Demand

North America emphasizes advanced injectable packaging, regulatory documentation, domestic resilience, and high-performance inspection. Latin America is shaped by public-health procurement, import dependence in selected applications, and the gradual strengthening of local pharmaceutical manufacturing. Europe combines demanding quality expectations with established glass and pharmaceutical capabilities, while the European Union places particular importance on harmonized regulation, sustainability, and supply-chain transparency. The Middle East is supported by healthcare investment and localization initiatives, with the GCC acting as a prominent procurement and manufacturing hub. Africa presents varied conditions, including expanding pharmaceutical access needs, infrastructure differences, and reliance on imported packaging. Asia-Pacific combines major pharmaceutical production centers, strong demand for sterile packaging, expanding biologics capacity, and diverse regulatory environments.

Group Insights: Trade, Regulation, and Investment Priorities Differ

ASEAN markets offer a diversified manufacturing and healthcare base, but qualification practices and regulatory maturity vary by country. BRICS economies combine substantial pharmaceutical demand with efforts to develop domestic production, strengthen strategic supply chains, and reduce exposure to external disruptions. The European Union supports cross-border regulatory alignment and sustainability initiatives. G7 members generally set demanding expectations for quality systems, advanced therapies, environmental performance, and supply security. NATO countries may place additional emphasis on medical preparedness and resilient critical supply networks. GCC members are prioritizing healthcare infrastructure, local industrial capability, and reliable access to essential medicines and packaging.

Country Insights: Distinct Regulatory and Manufacturing Conditions

Australia combines stringent medicine oversight with geographic supply-chain considerations. Brazil has a large healthcare system and pharmaceutical base, alongside complex regulatory and logistics conditions. Canada values dependable access, quality compliance, and integration with North American supply networks. China has extensive pharmaceutical and glass-manufacturing capabilities while continuing to strengthen quality and technology standards. France, Germany, Italy, and Spain benefit from deep European pharmaceutical ecosystems, with Germany particularly associated with industrial engineering and process precision. India combines large-scale pharmaceutical manufacturing with strong cost, quality, and export requirements. Japan emphasizes high reliability, process discipline, and advanced pharmaceutical packaging. Mexico is integrated into North American manufacturing and is developing broader pharmaceutical capabilities. Russia faces a distinct regulatory and supply environment shaped by domestic production priorities and trade constraints. South Korea is advancing biologics and high-value pharmaceutical manufacturing. The United Kingdom maintains rigorous medicine regulation and strong research and life-science capabilities. The United States remains highly influential in injectable medicines, contract manufacturing, regulatory expectations, and advanced delivery systems.

Actions for Leaders: Build Validated, Flexible, and Resilient Capabilities

Industry leaders should segment portfolios by formulation sensitivity, route of administration, sterilization exposure, and regulatory risk rather than treating all containers as interchangeable. They should qualify multiple sources of critical inputs, establish regional contingency plans, and use rigorous supplier audits covering raw materials, forming, annealing, inspection, cleaning, and packaging. Investment priorities should include automated defect detection, container-closure testing, extractables and leachables programs, energy-efficient furnaces, and auditable digital quality systems. AI deployments should begin with clearly bounded use cases and validation controls. Collaboration with pharmaceutical customers during development and change control can reduce qualification friction and improve lifecycle performance.

Research Methodology: Evidence-Based Market Interpretation

This executive summary uses the defined market scope of medicinal neutral borosilicate glass and interprets it through documented industry drivers, pharmaceutical packaging requirements, regulatory themes, manufacturing practices, and publicly established regional conditions. The analysis distinguishes regional, economic-group, and country-level context and avoids unsupported numerical claims. Insights are framed around application needs, quality assurance, technology adoption, supply resilience, and policy considerations rather than market estimates or forecasts. Any commercial decision should be validated against current regulatory documents, customer qualification requirements, supplier audits, and product-specific compatibility testing.

Conclusion: Quality Engineering and Supply Assurance Define Advantage

Medicinal neutral borosilicate glass remains strategically important because packaging performance directly supports pharmaceutical stability, sterility, and patient safety. The strongest positions will be built through consistent glass chemistry, precise forming, robust inspection, validated digital tools, environmental discipline, and resilient customer and supplier networks. Regional conditions differ, but the shared direction is clear: pharmaceutical manufacturers increasingly require dependable container performance, transparent quality evidence, and flexibility for complex injectable products.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Medicinal Neutral Borosilicate Glass Market, by Glass Type
7.1. Introduction
7.2. Low-Alkali Borosilicate Glass
7.3. Type I Neutral Borosilicate Glass
8. Medicinal Neutral Borosilicate Glass Market, by Product Form
8.1. Introduction
8.2. Vials & Ampoules
8.3. Syringes & Cartridges
8.4. Bottles & Containers
9. Medicinal Neutral Borosilicate Glass Market, by Manufacturing Process
9.1. Introduction
9.2. Molded Glass Products
9.3. Tubular Glass Products
10. Medicinal Neutral Borosilicate Glass Market, by Drug Compatibility
10.1. Introduction
10.2. Injectable Drug Packaging
10.3. Biologics & Vaccine Packaging
10.4. Lyophilized Drug Packaging
11. Medicinal Neutral Borosilicate Glass Market, by End User
11.1. Introduction
11.2. Biopharmaceutical Companies
11.3. Pharmaceutical Manufacturers
12. Medicinal Neutral Borosilicate Glass Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Medicinal Neutral Borosilicate Glass Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Medicinal Neutral Borosilicate Glass Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Asahi Glass Co., Ltd.
16.2. Borosil Glassworks Ltd.
16.3. Cangzhou Four Stars Glass Co., Ltd.
16.4. Corning Incorporated
16.5. Duran Group
16.6. Gerresheimer AG
16.7. Hilgenberg GmbH
16.8. Jiangsu Superior Glass
16.9. Junheng Hebei Pharmaceutical Glass Products Co., Ltd.
16.10. Lianyungang Zhongji Pharmaceutical Glass Co., Ltd.
16.11. Neubor Glass Co., Ltd.
16.12. Nippon Electric Glass Co., Ltd.
16.13. Nipro Corporation
16.14. Northstar Glassworks
16.15. Schott AG
16.16. SGD Pharma
16.17. Shandong Linuo Technical Glass Co., Ltd.
16.18. Triumph Group Inc.
16.19. Yaohui Group
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Medicinal Neutral Borosilicate Glass Market, Years Considered for the Study
FIGURE 2. Global Medicinal Neutral Borosilicate Glass Market, Research Design
FIGURE 3. Global Medicinal Neutral Borosilicate Glass Market, Research Framework
FIGURE 4. Global Medicinal Neutral Borosilicate Glass Market, Data Triangulation
FIGURE 5. Global Medicinal Neutral Borosilicate Glass Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Medicinal Neutral Borosilicate Glass Market Size, by Glass Type, 2025 vs 2032 (%)
FIGURE 7. Global Medicinal Neutral Borosilicate Glass Market Size, by Glass Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Medicinal Neutral Borosilicate Glass Market Size, by Product Form, 2025 vs 2032 (%)
FIGURE 9. Global Medicinal Neutral Borosilicate Glass Market Size, by Product Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Medicinal Neutral Borosilicate Glass Market Size, by Manufacturing Process, 2025 vs 2032 (%)
FIGURE 11. Global Medicinal Neutral Borosilicate Glass Market Size, by Manufacturing Process, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Medicinal Neutral Borosilicate Glass Market Size, by Drug Compatibility, 2025 vs 2032 (%)
FIGURE 13. Global Medicinal Neutral Borosilicate Glass Market Size, by Drug Compatibility, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Medicinal Neutral Borosilicate Glass Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Medicinal Neutral Borosilicate Glass Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Medicinal Neutral Borosilicate Glass Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Medicinal Neutral Borosilicate Glass Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Medicinal Neutral Borosilicate Glass Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Medicinal Neutral Borosilicate Glass Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Medicinal Neutral Borosilicate Glass Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Medicinal Neutral Borosilicate Glass Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Medicinal Neutral Borosilicate Glass Market Segmentation & Coverage
TABLE 2. Global Medicinal Neutral Borosilicate Glass Market Size, 2017-2032 (USD Million)
TABLE 3. Global Medicinal Neutral Borosilicate Glass Market Size, by Glass Type, 2017-2032 (USD Million)
TABLE 4. Global Low-Alkali Borosilicate Glass Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Low-Alkali Borosilicate Glass Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Low-Alkali Borosilicate Glass Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Type I Neutral Borosilicate Glass Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Type I Neutral Borosilicate Glass Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Type I Neutral Borosilicate Glass Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Medicinal Neutral Borosilicate Glass Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 11. Global Vials & Ampoules Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Vials & Ampoules Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Vials & Ampoules Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Syringes & Cartridges Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Syringes & Cartridges Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Syringes & Cartridges Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Bottles & Containers Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Bottles & Containers Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Bottles & Containers Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Medicinal Neutral Borosilicate Glass Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 21. Global Molded Glass Products Market Size, by Region, 2017-2032 (USD Million)
TABLE 22. Global Molded Glass Products Market Size, by Group, 2017-2032 (USD Million)
TABLE 23. Global Molded Glass Products Market Size, by Country, 2017-2032 (USD Million)
TABLE 24. Global Tubular Glass Products Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Tubular Glass Products Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Tubular Glass Products Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Medicinal Neutral Borosilicate Glass Market Size, by Drug Compatibility, 2017-2032 (USD Million)
TABLE 28. Global Injectable Drug Packaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Injectable Drug Packaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Injectable Drug Packaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Biologics & Vaccine Packaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Biologics & Vaccine Packaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Biologics & Vaccine Packaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Lyophilized Drug Packaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Lyophilized Drug Packaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Lyophilized Drug Packaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Medicinal Neutral Borosilicate Glass Market Size, by End User, 2017-2032 (USD Million)
TABLE 38. Global Biopharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Biopharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Biopharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Pharmaceutical Manufacturers Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Pharmaceutical Manufacturers Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Pharmaceutical Manufacturers Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Medicinal Neutral Borosilicate Glass Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Asia-Pacific Medicinal Neutral Borosilicate Glass Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Asia-Pacific Medicinal Neutral Borosilicate Glass Market Size, by Glass Type, 2017-2032 (USD Million)
TABLE 47. Asia-Pacific Medicinal Neutral Borosilicate Glass Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 48. Asia-Pacific Medicinal Neutral Borosilicate Glass Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 49. Asia-Pacific Medicinal Neutral Borosilicate Glass Market Size, by Drug Compatibility, 2017-2032 (USD Million)
TABLE 50. Asia-Pacific Medicinal Neutral Borosilicate Glass Market Size, by End User, 2017-2032 (USD Million)
TABLE 51. North America Medicinal Neutral Borosilicate Glass Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. North America Medicinal Neutral Borosilicate Glass Market Size, by Glass Type, 2017-2032 (USD Million)
TABLE 53. North America Medicinal Neutral Borosilicate Glass Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 54. North America Medicinal Neutral Borosilicate Glass Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 55. North America Medicinal Neutral Borosilicate Glass Market Size, by Drug Compatibility, 2017-2032 (USD Million)
TABLE 56. North America Medicinal Neutral Borosilicate Glass Market Size, by End User, 2017-2032 (USD Million)
TABLE 57. Latin America Medicinal Neutral Borosilicate Glass Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Latin America Medicinal Neutral Borosilicate Glass Market Size, by Glass Type, 2017-2032 (USD Million)
TABLE 59. Latin America Medicinal Neutral Borosilicate Glass Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 60. Latin America Medicinal Neutral Borosilicate Glass Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 61. Latin America Medicinal Neutral Borosilicate Glass Market Size, by Drug Compatibility, 2017-2032 (USD Million)
TABLE 62. Latin America Medicinal Neutral Borosilicate Glass Market Size, by End User, 2017-2032 (USD Million)
TABLE 63. Europe Medicinal Neutral Borosilicate Glass Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Europe Medicinal Neutral Borosilicate Glass Market Size, by Glass Type, 2017-2032 (USD Million)
TABLE 65. Europe Medicinal Neutral Borosilicate Glass Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 66. Europe Medicinal Neutral Borosilicate Glass Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 67. Europe Medicinal Neutral Borosilicate Glass Market Size, by Drug Compatibility, 2017-2032 (USD Million)
TABLE 68. Europe Medicinal Neutral Borosilicate Glass Market Size, by End User, 2017-2032 (USD Million)
TABLE 69. Middle East Medicinal Neutral Borosilicate Glass Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Middle East Medicinal Neutral Borosilicate Glass Market Size, by Glass Type, 2017-2032 (USD Million)
TABLE 71. Middle East Medicinal Neutral Borosilicate Glass Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 72. Middle East Medicinal Neutral Borosilicate Glass Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 73. Middle East Medicinal Neutral Borosilicate Glass Market Size, by Drug Compatibility, 2017-2032 (USD Million)
TABLE 74. Middle East Medicinal Neutral Borosilicate Glass Market Size, by End User, 2017-2032 (USD Million)
TABLE 75. Africa Medicinal Neutral Borosilicate Glass Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Africa Medicinal Neutral Borosilicate Glass Market Size, by Glass Type, 2017-2032 (USD Million)
TABLE 77. Africa Medicinal Neutral Borosilicate Glass Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 78. Africa Medicinal Neutral Borosilicate Glass Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 79. Africa Medicinal Neutral Borosilicate Glass Market Size, by Drug Compatibility, 2017-2032 (USD Million)
TABLE 80. Africa Medicinal Neutral Borosilicate Glass Market Size, by End User, 2017-2032 (USD Million)
TABLE 81. Global Medicinal Neutral Borosilicate Glass Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. ASEAN Medicinal Neutral Borosilicate Glass Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. ASEAN Medicinal Neutral Borosilicate Glass Market Size, by Glass Type, 2017-2032 (USD Million)
TABLE 84. ASEAN Medicinal Neutral Borosilicate Glass Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 85. ASEAN Medicinal Neutral Borosilicate Glass Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 86. ASEAN Medicinal Neutral Borosilicate Glass Market Size, by Drug Compatibility, 2017-2032 (USD Million)
TABLE 87. ASEAN Medicinal Neutral Borosilicate Glass Market Size, by End User, 2017-2032 (USD Million)
TABLE 88. GCC Medicinal Neutral Borosilicate Glass Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. GCC Medicinal Neutral Borosilicate Glass Market Size, by Glass Type, 2017-2032 (USD Million)
TABLE 90. GCC Medicinal Neutral Borosilicate Glass Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 91. GCC Medicinal Neutral Borosilicate Glass Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 92. GCC Medicinal Neutral Borosilicate Glass Market Size, by Drug Compatibility, 2017-2032 (USD Million)
TABLE 93. GCC Medicinal Neutral Borosilicate Glass Market Size, by End User, 2017-2032 (USD Million)
TABLE 94. European Union Medicinal Neutral Borosilicate Glass Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. European Union Medicinal Neutral Borosilicate Glass Market Size, by Glass Type, 2017-2032 (USD Million)
TABLE 96. European Union Medicinal Neutral Borosilicate Glass Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 97. European Union Medicinal Neutral Borosilicate Glass Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 98. European Union Medicinal Neutral Borosilicate Glass Market Size, by Drug Compatibility, 2017-2032 (USD Million)
TABLE 99. European Union Medicinal Neutral Borosilicate Glass Market Size, by End User, 2017-2032 (USD Million)
TABLE 100. BRICS Medicinal Neutral Borosilicate Glass Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. BRICS Medicinal Neutral Borosilicate Glass Market Size, by Glass Type, 2017-2032 (USD Million)
TABLE 102. BRICS Medicinal Neutral Borosilicate Glass Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 103. BRICS Medicinal Neutral Borosilicate Glass Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 104. BRICS Medicinal Neutral Borosilicate Glass Market Size, by Drug Compatibility, 2017-2032 (USD Million)
TABLE 105. BRICS Medicinal Neutral Borosilicate Glass Market Size, by End User, 2017-2032 (USD Million)
TABLE 106. G7 Medicinal Neutral Borosilicate Glass Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. G7 Medicinal Neutral Borosilicate Glass Market Size, by Glass Type, 2017-2032 (USD Million)
TABLE 108. G7 Medicinal Neutral Borosilicate Glass Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 109. G7 Medicinal Neutral Borosilicate Glass Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 110. G7 Medicinal Neutral Borosilicate Glass Market Size, by Drug Compatibility, 2017-2032 (USD Million)
TABLE 111. G7 Medicinal Neutral Borosilicate Glass Market Size, by End User, 2017-2032 (USD Million)
TABLE 112. NATO Medicinal Neutral Borosilicate Glass Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. NATO Medicinal Neutral Borosilicate Glass Market Size, by Glass Type, 2017-2032 (USD Million)
TABLE 114. NATO Medicinal Neutral Borosilicate Glass Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 115. NATO Medicinal Neutral Borosilicate Glass Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 116. NATO Medicinal Neutral Borosilicate Glass Market Size, by Drug Compatibility, 2017-2032 (USD Million)
TABLE 117. NATO Medicinal Neutral Borosilicate Glass Market Size, by End User, 2017-2032 (USD Million)
TABLE 118. Global Medicinal Neutral Borosilicate Glass Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. United States Medicinal Neutral Borosilicate Glass Market Size, 2017-2032 (USD Million)
TABLE 120. United States Medicinal Neutral Borosilicate Glass Market Size, by Glass Type, 2017-2032 (USD Million)
TABLE 121. United States Medicinal Neutral Borosilicate Glass Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 122. United States Medicinal Neutral Borosilicate Glass Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 123. United States Medicinal Neutral Borosilicate Glass Market Size, by Drug Compatibility, 2017-2032 (USD Million)
TABLE 124. United States Medicinal Neutral Borosilicate Glass Market Size, by End User, 2017-2032 (USD Million)
TABLE 125. Canada Medicinal Neutral Borosilicate Glass Market Size, 2017-2032 (USD Million)
TABLE 126. Canada Medicinal Neutral Borosilicate Glass Market Size, by Glass Type, 2017-2032 (USD Million)
TABLE 127. Canada Medicinal Neutral Borosilicate Glass Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 128. Canada Medicinal Neutral Borosilicate Glass Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 129. Canada Medicinal Neutral Borosilicate Glass Market Size, by Drug Compatibility, 2017-2032 (USD Million)
TABLE 130. Canada Medicinal Neutral Borosilicate Glass Market Size, by End User, 2017-2032 (USD Million)
TABLE 131. Mexico Medicinal Neutral Borosilicate Glass Market Size, 2017-2032 (USD Million)
TABLE 132. Mexico Medicinal Neutral Borosilicate Glass Market Size, by Glass Type, 2017-2032 (USD Million)
TABLE 133. Mexico Medicinal Neutral Borosilicate Glass Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 134. Mexico Medicinal Neutral Borosilicate Glass Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 135. Mexico Medicinal Neutral Borosilicate Glass Market Size, by Drug Compatibility, 2017-2032 (USD Million)
TABLE 136. Mexico Medicinal Neutral Borosilicate Glass Market Size, by End User, 2017-2032 (USD Million)
TABLE 137. Brazil Medicinal Neutral Borosilicate Glass Market Size, 2017-2032 (USD Million)
TABLE 138. Brazil Medicinal Neutral Borosilicate Glass Market Size, by Glass Type, 2017-2032 (USD Million)
TABLE 139. Brazil Medicinal Neutral Borosilicate Glass Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 140. Brazil Medicinal Neutral Borosilicate Glass Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 141. Brazil Medicinal Neutral Borosilicate Glass Market Size, by Drug Compatibility, 2017-2032 (USD Million)
TABLE 142. Brazil Medicinal Neutral Borosilicate Glass Market Size, by End User, 2017-2032 (USD Million)
TABLE 143. United Kingdom Medicinal Neutral Borosilicate Glass Market Size, 2017-2032 (USD Million)
TABLE 144. United Kingdom Medicinal Neutral Borosilicate Glass Market Size, by Glass Type, 2017-2032 (USD Million)
TABLE 145. United Kingdom Medicinal Neutral Borosilicate Glass Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 146. United Kingdom Medicinal Neutral Borosilicate Glass Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 147. United Kingdom Medicinal Neutral Borosilicate Glass Market Size, by Drug Compatibility, 2017-2032 (USD Million)
TABLE 148. United Kingdom Medicinal Neutral Borosilicate Glass Market Size, by End User, 2017-2032 (USD Million)
TABLE 149. Germany Medicinal Neutral Borosilicate Glass Market Size, 2017-2032 (USD Million)
TABLE 150. Germany Medicinal Neutral Borosilicate Glass Market Size, by Glass Type, 2017-2032 (USD Million)
TABLE 151. Germany Medicinal Neutral Borosilicate Glass Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 152. Germany Medicinal Neutral Borosilicate Glass Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 153. Germany Medicinal Neutral Borosilicate Glass Market Size, by Drug Compatibility, 2017-2032 (USD Million)
TABLE 154. Germany Medicinal Neutral Borosilicate Glass Market Size, by End User, 2017-2032 (USD Million)
TABLE 155. France Medicinal Neutral Borosilicate Glass Market Size, 2017-2032 (USD Million)
TABLE 156. France Medicinal Neutral Borosilicate Glass Market Size, by Glass Type, 2017-2032 (USD Million)
TABLE 157. France Medicinal Neutral Borosilicate Glass Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 158. France Medicinal Neutral Borosilicate Glass Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 159. France Medicinal Neutral Borosilicate Glass Market Size, by Drug Compatibility, 2017-2032 (USD Million)
TABLE 160. France Medicinal Neutral Borosilicate Glass Market Size, by End User, 2017-2032 (USD Million)
TABLE 161. Russia Medicinal Neutral Borosilicate Glass Market Size, 2017-2032 (USD Million)
TABLE 162. Russia Medicinal Neutral Borosilicate Glass Market Size, by Glass Type, 2017-2032 (USD Million)
TABLE 163. Russia Medicinal Neutral Borosilicate Glass Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 164. Russia Medicinal Neutral Borosilicate Glass Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 165. Russia Medicinal Neutral Borosilicate Glass Market Size, by Drug Compatibility, 2017-2032 (USD Million)
TABLE 166. Russia Medicinal Neutral Borosilicate Glass Market Size, by End User, 2017-2032 (USD Million)
TABLE 167. Italy Medicinal Neutral Borosilicate Glass Market Size, 2017-2032 (USD Million)
TABLE 168. Italy Medicinal Neutral Borosilicate Glass Market Size, by Glass Type, 2017-2032 (USD Million)
TABLE 169. Italy Medicinal Neutral Borosilicate Glass Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 170. Italy Medicinal Neutral Borosilicate Glass Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 171. Italy Medicinal Neutral Borosilicate Glass Market Size, by Drug Compatibility, 2017-2032 (USD Million)
TABLE 172. Italy Medicinal Neutral Borosilicate Glass Market Size, by End User, 2017-2032 (USD Million)
TABLE 173. Spain Medicinal Neutral Borosilicate Glass Market Size, 2017-2032 (USD Million)
TABLE 174. Spain Medicinal Neutral Borosilicate Glass Market Size, by Glass Type, 2017-2032 (USD Million)
TABLE 175. Spain Medicinal Neutral Borosilicate Glass Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 176. Spain Medicinal Neutral Borosilicate Glass Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 177. Spain Medicinal Neutral Borosilicate Glass Market Size, by Drug Compatibility, 2017-2032 (USD Million)
TABLE 178. Spain Medicinal Neutral Borosilicate Glass Market Size, by End User, 2017-2032 (USD Million)
TABLE 179. China Medicinal Neutral Borosilicate Glass Market Size, 2017-2032 (USD Million)
TABLE 180. China Medicinal Neutral Borosilicate Glass Market Size, by Glass Type, 2017-2032 (USD Million)
TABLE 181. China Medicinal Neutral Borosilicate Glass Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 182. China Medicinal Neutral Borosilicate Glass Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 183. China Medicinal Neutral Borosilicate Glass Market Size, by Drug Compatibility, 2017-2032 (USD Million)
TABLE 184. China Medicinal Neutral Borosilicate Glass Market Size, by End User, 2017-2032 (USD Million)
TABLE 185. India Medicinal Neutral Borosilicate Glass Market Size, 2017-2032 (USD Million)
TABLE 186. India Medicinal Neutral Borosilicate Glass Market Size, by Glass Type, 2017-2032 (USD Million)
TABLE 187. India Medicinal Neutral Borosilicate Glass Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 188. India Medicinal Neutral Borosilicate Glass Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 189. India Medicinal Neutral Borosilicate Glass Market Size, by Drug Compatibility, 2017-2032 (USD Million)
TABLE 190. India Medicinal Neutral Borosilicate Glass Market Size, by End User, 2017-2032 (USD Million)
TABLE 191. Japan Medicinal Neutral Borosilicate Glass Market Size, 2017-2032 (USD Million)
TABLE 192. Japan Medicinal Neutral Borosilicate Glass Market Size, by Glass Type, 2017-2032 (USD Million)
TABLE 193. Japan Medicinal Neutral Borosilicate Glass Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 194. Japan Medicinal Neutral Borosilicate Glass Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 195. Japan Medicinal Neutral Borosilicate Glass Market Size, by Drug Compatibility, 2017-2032 (USD Million)
TABLE 196. Japan Medicinal Neutral Borosilicate Glass Market Size, by End User, 2017-2032 (USD Million)
TABLE 197. Australia Medicinal Neutral Borosilicate Glass Market Size, 2017-2032 (USD Million)
TABLE 198. Australia Medicinal Neutral Borosilicate Glass Market Size, by Glass Type, 2017-2032 (USD Million)
TABLE 199. Australia Medicinal Neutral Borosilicate Glass Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 200. Australia Medicinal Neutral Borosilicate Glass Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 201. Australia Medicinal Neutral Borosilicate Glass Market Size, by Drug Compatibility, 2017-2032 (USD Million)
TABLE 202. Australia Medicinal Neutral Borosilicate Glass Market Size, by End User, 2017-2032 (USD Million)
TABLE 203. South Korea Medicinal Neutral Borosilicate Glass Market Size, 2017-2032 (USD Million)
TABLE 204. South Korea Medicinal Neutral Borosilicate Glass Market Size, by Glass Type, 2017-2032 (USD Million)
TABLE 205. South Korea Medicinal Neutral Borosilicate Glass Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 206. South Korea Medicinal Neutral Borosilicate Glass Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 207. South Korea Medicinal Neutral Borosilicate Glass Market Size, by Drug Compatibility, 2017-2032 (USD Million)
TABLE 208. South Korea Medicinal Neutral Borosilicate Glass Market Size, by End User, 2017-2032 (USD Million)
TABLE 209. Global Medicinal Neutral Borosilicate Glass Market Share, by Key Player, 2025
TABLE 210. Global Medicinal Neutral Borosilicate Glass Market, Key Experts

Companies Mentioned

  • Asahi Glass Co., Ltd.
  • Borosil Glassworks Ltd.
  • Cangzhou Four Stars Glass Co., Ltd.
  • Corning Incorporated
  • Duran Group
  • Gerresheimer AG
  • Hilgenberg GmbH
  • Jiangsu Superior Glass
  • Junheng Hebei Pharmaceutical Glass Products Co., Ltd.
  • Lianyungang Zhongji Pharmaceutical Glass Co., Ltd.
  • Neubor Glass Co., Ltd.
  • Nippon Electric Glass Co., Ltd.
  • Nipro Corporation
  • Northstar Glassworks
  • Schott AG
  • SGD Pharma
  • Shandong Linuo Technical Glass Co., Ltd.
  • Triumph Group Inc.
  • Yaohui Group

Related Topics

Related Reports

Glass Medicine Bottles Market - Global Strategic Business Report - Product Image

Glass Medicine Bottles Market - Global Strategic Business Report

  • Report
  • 375 Pages
  • Global
From
Medium Borosilicate Medicinal Glass Tube Sales Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Medium Borosilicate Medicinal Glass Tube Sales Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Pharma Glass Tubing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Pharma Glass Tubing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 120 Pages
  • Global
From
Borosilicate Glass Microfiber Filter Market - Global Forecast 2026-2032 - Product Image

Borosilicate Glass Microfiber Filter Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Borosilicate Glass Market - Global Forecast 2026-2032 - Product Image

Borosilicate Glass Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.